Zenas BioPharma, Inc. Share Price

Zenas BioPharma, Inc. Share Price

NASDAQ: ZBIO | Small Cap
$28.38
-$0.45 (-1.58%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Zenas BioPharma, Inc. Stock Performance

Open
$28.23
Prev. Close
$28.83
Circuit Range
N/A
Day Range
$28.02 - $28.75
Year Range
$13.51 - $44.52
Volume
21,521
Average Traded
$28.29

Zenas BioPharma, Inc. Share Price Today

As of 31 October 2026, Zenas BioPharma, Inc.'s share price is $28.38. The stock opened at $28.23, compared to its previous close of $28.83. During today's trading session, Zenas BioPharma, Inc.'s share price traded between $28.02 and $28.75, with an average price of $28.38. Over the past 52 weeks, the stock has recorded a high of $44.52 and a low of $13.51. In terms of performance, Zenas BioPharma, Inc.'s share price has risen by 46.64% over the last six months and is down 9.21% on a year-on-year basis.

Zenas BioPharma, Inc. Share Price Chart

Line chart of the Zenas BioPharma, Inc. price trend over the selected period. The price fell overall, ranging from 27.86 to 28.75, ending at 28.38.
$28.02$28.75
L
Show Current Price
H

Zenas BioPharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.27B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-7.43
Revenue (TTM)
$10.00B
Return On Equity (TTM)
-196.03%
Profit Margin
-3777.40%
Debt to Equity
1.20
Quarterly Earnings Growth YoY
-116.43%

Zenas BioPharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$1.00
Net Profit-$51.50-$240.44-$80.99-$111.46
Net Profit MarginN/AN/AN/A-11146.00%
Income ChangeN/A-366.87%66.32%-37.62%

Zenas BioPharma, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$5.00$10.00
Net Profit-$156.99-$377.74
Net Profit Margin-3139.80%-3777.40%
Income ChangeN/A-140.61%

About Zenas BioPharma, Inc.

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.

Zenas BioPharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$26.84
$28.39
+4.86%
Sep 2026
$32.13
$27.07
-17.08%
Aug 2026
$31.88
$32.65
+3.88%
Jul 2026
$25.91
$31.43
+23.99%
Jun 2026
$18.05
$25.34
+37.82%
May 2026
$18.86
$18.39
-4.96%
Apr 2026
$20.38
$19.35
-0.97%
Mar 2026
$25.11
$19.54
-25.82%
Feb 2026
$18.30
$26.34
+43.42%
Jan 2026
$36.63
$18.36
-49.31%
Dec 2025
$37.83
$36.23
-7.13%
Nov 2025
$30.90
$39.01
+24.81%

ZBIO Share Price FAQs